Second, if there was evidence of genetic effect of the SGLT2 instruments on expression levels of other genes, where the expression levels of these genes were associated with prostate cancer, then this will violate the exclusion restriction assumption of MR. The gene discussed is SLC5A2; the disease is Familial prostate cancer.